Improved arterial spin labeling after myocardial infarction in mice using cardiac and respiratory gated look-locker imaging with fuzzy C-means clustering.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMC 2918386)

Published in Magn Reson Med on March 01, 2010

Authors

Moriel H Vandsburger1, Robert L Janiczek, Yaqin Xu, Brent A French, Craig H Meyer, Christopher M Kramer, Frederick H Epstein

Author Affiliations

1: Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22908, USA.

Articles citing this

Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes. Radiology (2012) 1.58

Phenotyping of left and right ventricular function in mouse models of compensated hypertrophy and heart failure with cardiac MRI. PLoS One (2013) 0.87

Cardiac perfusion imaging using hyperpolarized (13) c urea using flow sensitizing gradients. Magn Reson Med (2015) 0.85

Accelerated dual-contrast first-pass perfusion MRI of the mouse heart: development and application to diet-induced obese mice. Magn Reson Med (2014) 0.85

Cardiac MR imaging: current status and future direction. Cardiovasc Diagn Ther (2015) 0.84

Emerging MRI methods in translational cardiovascular research. J Cardiovasc Transl Res (2011) 0.84

Hyperemic stress myocardial perfusion cardiovascular magnetic resonance in mice at 3 Tesla: initial experience and validation against microspheres. J Cardiovasc Magn Reson (2013) 0.83

In vivo characterization of rodent cyclic myocardial perfusion variation at rest and during adenosine-induced stress using cine-ASL cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.81

Regional contrast agent quantification in a mouse model of myocardial infarction using 3D cardiac T1 mapping. J Cardiovasc Magn Reson (2011) 0.79

Spin-labeling magnetic resonance imaging detects increased myocardial blood flow after endothelial cell transplantation in the infarcted heart. Circ Cardiovasc Imaging (2012) 0.79

Improve myocardial T1 measurement in rats with a new regression model: application to myocardial infarction and beyond. Magn Reson Med (2013) 0.78

Quantitative myocardial perfusion in mice based on the signal intensity of flow sensitized CMR. J Cardiovasc Magn Reson (2012) 0.77

Myocardial arterial spin labeling perfusion imaging with improved sensitivity. J Cardiovasc Magn Reson (2014) 0.76

Repeatability and variability of myocardial perfusion imaging techniques in mice: Comparison of arterial spin labeling and first-pass contrast-enhanced MRI. Magn Reson Med (2015) 0.75

Rapid multislice T1 mapping of mouse myocardium: Application to quantification of manganese uptake in α-Dystrobrevin knockout mice. Magn Reson Med (2014) 0.75

Myocardial arterial spin labeling. J Cardiovasc Magn Reson (2016) 0.75

Imaging Cell Therapy for Myocardial Regeneration. Curr Cardiovasc Imaging Rep (2011) 0.75

Articles cited by this

The immune system and cardiac repair. Pharmacol Res (2008) 3.42

Fast spiral coronary artery imaging. Magn Reson Med (1992) 2.96

Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation (2004) 2.46

Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol (2008) 1.71

Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med (2001) 1.65

Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction. Magn Reson Med (2002) 1.44

In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn Reson Med (2005) 1.31

In vivo quantitative mapping of cardiac perfusion in rats using a noninvasive MR spin-labeling method. J Magn Reson Imaging (1999) 1.30

Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magn Reson Med (2005) 1.28

Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation (2002) 1.28

Brain perfusion territory imaging: methods and clinical applications of selective arterial spin-labeling MR imaging. Radiology (2008) 1.27

Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J (2007) 1.26

MR in mouse models of cardiac disease. NMR Biomed (2007) 1.25

Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn Reson Med (2005) 1.25

Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol (2000) 1.16

Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Cardiovasc Pathol (2006) 1.13

Magnetization exchange in capillaries by microcirculation affects diffusion-controlled spin-relaxation: a model which describes the effect of perfusion on relaxation enhancement by intravascular contrast agents. Magn Reson Med (1996) 1.12

Rodent models of heart failure. J Pharmacol Toxicol Methods (2007) 1.10

Measurement of human myocardial perfusion by double-gated flow alternating inversion recovery EPI. Magn Reson Med (1999) 1.09

Adaptive postprocessing techniques for myocardial tissue tracking with displacement-encoded MR imaging. Radiology (2008) 1.07

Multimodal functional cardiac MRI in creatine kinase-deficient mice reveals subtle abnormalities in myocardial perfusion and mechanics. Am J Physiol Heart Circ Physiol (2006) 1.07

Quantitative assessment of myocardial perfusion with a spin-labeling technique: preliminary results in patients with coronary artery disease. J Magn Reson Imaging (2003) 1.05

High-resolution myocardial perfusion mapping in small animals in vivo by spin-labeling gradient-echo imaging. Magn Reson Med (2004) 1.04

Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. Radiology (2000) 1.03

In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia. J Magn Reson Imaging (2005) 0.97

Resting myocardial perfusion quantification with CMR arterial spin labeling at 1.5 T and 3.0 T. J Cardiovasc Magn Reson (2008) 0.94

Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice. J Am Coll Cardiol (2007) 0.91

Serial magnetic resonance imaging of microvascular remodeling in the infarcted rat heart. Circulation (2001) 0.89

Defective myocardial blood flow and altered function of the left ventricle in type 2 diabetic rats: a noninvasive in vivo study using perfusion and cine magnetic resonance imaging. Invest Radiol (2005) 0.89

Noninvasive characterization of myocardial blood flow in diabetic, hypertensive, and diabetic-hypertensive rats using spin-labeling MRI. Microcirculation (2005) 0.86

Impaired resting perfusion in viable myocardium distal to chronic coronary stenosis in rats. Am J Physiol Heart Circ Physiol (2005) 0.85

Myocardial perfusion measurements by spin-labeling under different vasodynamic states. J Cardiovasc Magn Reson (2004) 0.84

Noninvasive imaging of angiogenesis inhibition following nitric oxide synthase blockade in the ischemic rat heart in vivo. Microcirculation (2005) 0.79

Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction. Microvasc Res (2007) 0.79

Articles by these authors

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation (2009) 8.11

ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology. J Am Coll Cardiol (2006) 7.77

ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol (2010) 4.16

Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87

Myocardial tissue tracking with two-dimensional cine displacement-encoded MR imaging: development and initial evaluation. Radiology (2004) 3.59

Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17

Multifactorial determinants of functional capacity in peripheral arterial disease: uncoupling of calf muscle perfusion and metabolism. J Am Coll Cardiol (2009) 2.81

Elevated circulating fibrocyte levels in patients with hypertensive heart disease. J Hypertens (2012) 2.79

Tracking myocardial motion from cine DENSE images using spatiotemporal phase unwrapping and temporal fitting. IEEE Trans Med Imaging (2007) 2.55

Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging (2012) 2.53

Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation (2004) 2.46

ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol (2013) 2.29

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23

ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14

Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J Cardiovasc Magn Reson (2008) 2.08

Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging (2013) 2.02

Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation (2006) 1.94

Technology insight: in vivo cell tracking by use of MRI. Nat Clin Pract Cardiovasc Med (2006) 1.89

Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol (2003) 1.88

Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82

Imaging three-dimensional myocardial mechanics using navigator-gated volumetric spiral cine DENSE MRI. Magn Reson Med (2010) 1.78

MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn Reson Med (2002) 1.77

Collagen-targeted MRI contrast agent for molecular imaging of fibrosis. Angew Chem Int Ed Engl (2007) 1.75

Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation (2005) 1.75

The effect of ezetimibe on peripheral arterial atherosclerosis depends upon statin use at baseline. Atherosclerosis (2011) 1.70

Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 1.69

Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68

Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation (2014) 1.67

Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding. Am J Physiol Heart Circ Physiol (2004) 1.67

ACC/AHA/ACR/ASE/ASNC/HRS/NASCI/RSNA/SAIP/SCAI/ SCCT/SCMR/SIR 2008 Key Data Elements and Definitions for Cardiac Imaging: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). Circulation (2008) 1.62

Monocyte and/or macrophage infiltration of heart after myocardial infarction: MR imaging by using T1-shortening liposomes. Radiology (2012) 1.58

Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease. J Am Coll Cardiol (2011) 1.58

Assessment of the accuracy and reproducibility of RV volume measurements by CMR in congenital heart disease. JACC Cardiovasc Imaging (2012) 1.54

Calf muscle perfusion at peak exercise in peripheral arterial disease: measurement by first-pass contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2007) 1.54

Assessment of advanced coronary artery disease: advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol (2010) 1.53

Cost and yield of adding electrocardiography to history and physical in screening Division I intercollegiate athletes: a 5-year experience. Heart Rhythm (2010) 1.52

Percutaneous intervention in peripheral artery disease improves calf muscle phosphocreatine recovery kinetics: a pilot study. Vasc Med (2012) 1.48

Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology (2008) 1.48

Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging (2008) 1.48

Quantification and MRI validation of regional contractile dysfunction in mice post myocardial infarction using high resolution ultrasound. Ultrasound Med Biol (2007) 1.48

Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling. Circ Cardiovasc Imaging (2013) 1.46

Serial MRI evaluation of cardiac structure and function in mice after reperfused myocardial infarction. Magn Reson Med (2002) 1.44

Reproducibility and reliability of atherosclerotic plaque volume measurements in peripheral arterial disease with cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 1.40

Motion-guided segmentation for cine DENSE MRI. Med Image Anal (2008) 1.40

High left ventricular mass index does not limit the utility of fractional flow reserve for the physiologic assessment of lesion severity. J Invasive Cardiol (2006) 1.40

Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J Am Coll Cardiol (2006) 1.35

Small-animal molecular imaging methods. J Nucl Med (2010) 1.32

Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magn Reson Med (2005) 1.28

Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab (2008) 1.28

Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation (2002) 1.28

Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol (2005) 1.26

Multi-parameter in vivo cardiac magnetic resonance imaging demonstrates normal perfusion reserve despite severely attenuated beta-adrenergic functional response in neuronal nitric oxide synthase knockout mice. Eur Heart J (2007) 1.26

Multimodality cardiovascular molecular imaging, part I. Circ Cardiovasc Imaging (2008) 1.25

Complementary displacement-encoded MRI for contrast-enhanced infarct detection and quantification of myocardial function in mice. Magn Reson Med (2004) 1.22

Early assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc Imaging (2010) 1.22

Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells (2007) 1.20

Comparison of methods for determining the partition coefficient of gadolinium in the myocardium using T1 mapping. J Magn Reson Imaging (2012) 1.19